Guggenheim Sees Compass (CMPX) Potential Driven by Biliary Tract Cancer Pipeline
Compass Therapeutics Inc. (NASDAQ:CMPX) is one of the best multibagger stocks to invest in right now.
Compass Therapeutics Inc. (CMPX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 15,219,994 | $39,571,984 | -32% | 0.99% |
| 2. | Tang Capital Management Kevin C. Tang | 13,496,208 | $35,090,141 | +23% | 1.77% |
| 3. | Enavate Sciences James Boylan | 7,788,150 | $20,249,190 | 11.47% | |
| 4. | Suvretta Capital Management Aaron Cowen | 7,149,493 | $18,588,682 | 0.56% | |
| 5. | Vivo Capital Albert Cha And Frank Kung | 6,043,466 | $15,713,012 | +70% | 1.61% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.11 | 10,000 | $21,100.00 | 6,480,825 | 2025-05-27 | Filing | |
| $1.54 | 20,000 | $30,800.00 | 21,000 | 2025-04-07 | Filing | |
| $1.42 | 20,000 | $28,400.00 | 320,000 | 2025-04-07 | Filing | |
| $3.37 | 10,000 | $33,700.00 | 6,021,873 | 2023-03-10 | Filing | |
| $3.98 | 20,000 | $79,600.00 | 6,011,873 | 2023-02-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.59 | 3,571,428 | $5,678,570.52 | 0 | 2025-04-09 | Filing | |
| $1.59 | 3,571,428 | $5,678,570.52 | 0 | 2025-04-09 | Filing | |
| $4.36 | 2 | $8.72 | 1,060,414 | 2022-11-25 | Filing | |
| $4.30 | 9,569 | $41,146.70 | 1,060,416 | 2022-11-23 | Filing | |
| $4.19 | 14,929 | $62,552.51 | 1,069,985 | 2022-11-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,025,151 | $26,065,393 | 0.11% | |
| 2. | 6,413,133 | $16,674,146 | 0% | |
| 3. | 4,850,005 | $12,610,013 | 0% | |
| 4. | 4,134,655 | $10,750,103 | 0% | |
| 5. | 2,591,525 | $6,737,965 | 2.17% |
News See All
15 Best Multibagger Stocks to Invest in Right Now
Just as a single diamond can outshine a handful of pebbles, a well-chosen multibagger can transform an ordinary portfolio into an extraordinary one.
Piper Sandler Reaffirms Optimism on Compass Therapeutics (CMPX) Amid Trial Update
Compass Therapeutics, Inc. (NASDAQ:CMPX) is one of the must-buy penny stocks to invest in.
10 Must-Buy Penny Stocks to Invest In
According to the LSEG 2025 Mid-Year Outlook, small-cap earnings are projected to grow 40.8% in 2025, compared to 8.8% for the S&P 500.
Compass Therapeutics (CMPX) Rated ‘Outperform’ amid Clinical Pipeline Development
Compass Therapeutics, Inc. (NASDAQ:CMPX) is one of the top multibagger penny stocks to buy, according to analysts.
13 Best Multibagger Penny Stocks to Buy According to Analysts
It’s time to pivot towards micro and small-cap stocks as the US Federal Reserve prepares to cut interest rates.
10 Best Performing Penny Stocks So Far in 2025
By midday Wednesday, July 23, 2025, the Russell 2000 was up 1.57% for the week. This compares to a 0.9% gain for the S&P 500.
Compass Therapeutics (CMPX) Gains Analyst Confidence with Promising Cancer Pipeline
Compass Therapeutics, Inc. (NASDAQ:CMPX) is one of the top high-return penny stocks to buy now. On July 14, Stifel reiterated its Buy rating and $11.00 price target for CMPX.
11 Best High Return Penny Stocks to Buy Now
US equity markets are back at all-time highs amid a muted response to new U.S. tariffs and the trade war. The Nasdaq Composite Index, performing relatively well among major U.S.
10 Hot Biotech Stocks Under $5
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Hedge Fund Resource Center Billionaire Hedge Funds
